TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/24 09:33 | 9/24/24 | RPHM | Reneo Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 5 | P.m | 1,725 | 1.44 | 0 | 1,199 | 37 | 4,478 | I | ||||||||||||||
9/9/24 16:24 | 9/5/24 | TLIS | Talis Biomedical Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | 1 | 4 | P.m | 103 | 2.28 | 0 | 45 | 22 | 249 | I | ||||||||||||||
8/14/24 20:24 | 8/14/24 | ANTX | An2 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P | 1,560 | 1.04 | 0 | 1,500 | 35 | 5,749 | I | ||||||||||||||
8/5/24 15:57 | 8/2/24 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 7 | P.m | 5,592 | 1.15 | 0 | 4,854 | 21 | 28,294 | I | ||||||||||||||
7/31/24 16:19 | 7/30/24 | ADVM | Adverum Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 2 | P.m | 2,399 | 7.94 | 0 | 302 | 15 | 2,373 | I | ||||||||||||||
5/15/24 11:21 | 5/13/24 | AVRO | Avrobio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 1 | P.m | 971 | 1.27 | 0 | 767 | 17 | 5,168 | I | ||||||||||||||
3/25/24 11:05 | 3/20/24 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 2 | P | 846 | 2.97 | 0 | 284 | 8 | 3,989 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |